Search results for "secret"

showing 10 items of 1132 documents

Mucus and MUC in asthma.

2005

Asthma is characterized by chronic airway inflammation and a mucus hypersecretory phenotype comprising excess mucus secretion, goblet cell hyperplasia and submucosal gland hypertrophy. This augmented mucus secretion has been relatively undervalued in asthma compared with airway inflammation. However, mucus plugging contributes to airflow limitation and airway hyperresponsiveness, and to morbidity and mortality in asthma. We review recent contributions to this field and therapeutic avenues to control mucus hypersecretion.A distinct mucus hypersecretory phenotype may present in asthma. Overexpression of MUC5AC, MUC5B and MUC2 have been described in asthma secretions, but identification of def…

Pulmonary and Respiratory MedicineGoblet cell hyperplasiabusiness.industryMucinMucinsRespiratory Mucosarespiratory systemmedicine.diseaseMucusPhenotypeAsthmarespiratory tract diseasesMuscle hypertrophyMucusfluids and secretionsPhenotypeImmunologyChronic DiseaseMedicineHumansSecretionbusinessAirwayAsthmaCurrent opinion in pulmonary medicine
researchProduct

Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis.

1992

An activation of T-cells that is restricted to the lung has been demonstrated in pulmonary sarcoidosis. The role of blood monocytes (MO) and alveolar macrophages (AM) in this concept of compartmentalized inflammation has not yet been evaluated. In order to elucidate this question, we measured the release of tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) by peripheral blood mononuclear cells (PBMNC) and AM in 43 patients with sarcoidosis (32 with active, 11 with inactive disease) without therapy and correlated the spontaneous monokine release to parameters of the T-cell alveolitis and the course of the disease. TNF alpha as well as IL-1 were spontaneously released by AM of …

Pulmonary and Respiratory MedicineInterleukin 2Lung Diseasesmedicine.medical_specialtyTime FactorsSarcoidosisLung Diseases/metabolism610 MedizinInflammationSarcoidosis/metabolismLymphocyte ActivationMacrophages Alveolar/secretionPeripheral blood mononuclear cellMonocytesInterleukin-1/secretionInternal medicineMacrophages AlveolarmedicineMacrophageHumansddc:610Receptors Interleukin-2/metabolismTumor Necrosis Factor-alpha/secretionbusiness.industryTumor Necrosis Factor-alphaMonocyteLeukocytes Mononuclear/secretionMonocytes/immunologyReceptors Interleukin-2Macrophage ActivationMonokinemedicine.anatomical_structureEndocrinologyImmunologyAlveolar macrophageLeukocytes MononuclearInterleukin-2Tumor necrosis factor alphamedicine.symptomInterleukin-2/secretionbusinessmedicine.drugInterleukin-1The American review of respiratory disease
researchProduct

Persistent Tachypnea of Infancy. Usual and Aberrant.

2016

Persistent tachypnea of infancy (PTI) is a specific clinical entity of undefined etiology comprising the two diseases neuroendocrine cell hyperplasia of infancy (NEHI) and pulmonary interstitial glycogenosis. The outcome of typical NEHI is favorable. The outcome may be different for patients without a typical NEHI presentation, and thus a lung biopsy to differentiate the diseases is indicated.To determine whether infants with the characteristic clinical presentation and computed tomographic (CT) imaging of NEHI (referred to as "usual PTI") have long-term outcome and biopsy findings similar to those of infants with an aberrant presentation and/or with additional localized minor CT findings (…

Pulmonary and Respiratory MedicineMalePathologymedicine.medical_specialtyBiopsyLung biopsyCritical Care and Intensive Care MedicineTachypneaCohort Studies03 medical and health sciences0302 clinical medicineNeuroendocrine Cells030225 pediatricsBiopsymedicineHumansMedical historyChildLungRetrospective StudiesTachypneaLungHyperplasiamedicine.diagnostic_testbusiness.industryInfant NewbornInfantRetrospective cohort studyGlycogen Storage DiseaseNeurosecretory Systemsmedicine.anatomical_structure030228 respiratory systemChild PreschoolEtiologyFemaleRadiologymedicine.symptombusinessLung Diseases InterstitialTomography X-Ray ComputedCohort studyFollow-Up StudiesAmerican journal of respiratory and critical care medicine
researchProduct

Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.

2012

We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (GSMs) with a unique pharmacological profile. Our strategy included (i) virtual screening through application of a recently developed protocol (PhAST), (ii) synthetic chemistry to discover structure–activity relationships, and (iii) detailed in vitro pharmacological characterization. GSMs are promising agents for treatment or prevention of Alzheimer’s disease. They modulate the γ-secretase product spectrum (i.e., amyloid-β (Aβ) peptides of different length) and induce a shift from toxic Aβ42 to shorter Aβ species such as Aβ38 with no or minimal effect on the overall rate of γ-secretase cleavag…

PyridinesPyridonesMolecular Sequence DataPeptideComputational biologyCHO CellsBiochemistryStructure-Activity RelationshipAlzheimer DiseaseCricetinaeAnimalsHumansγ secretaseAmino Acid Sequencechemistry.chemical_classificationVirtual screeningActivity profileAmyloid beta-PeptidesChemistryGeneral MedicineIntegrated approachIn vitroMinimal effectDrug DesignMolecular MedicineAmyloid Precursor Protein SecretasesACS chemical biology
researchProduct

Pulsed Electric Fields Alter Expression of NF-κB Promoter-Controlled Gene

2021

The possibility to artificially adjust and fine‐tune gene expression is one of the key mile-stones in bioengineering, synthetic biology, and advanced medicine. Since the effects of proteins or other transgene products depend on the dosage, controlled gene expression is required for any ap-plications, where even slight fluctuations of the transgene product impact its function or other critical cell parameters. In this context, physical techniques demonstrate optimistic perspectives, and pulsed electric field technology is a potential candidate for a noninvasive, biophysical gene regulator, exploiting an easily adjustable pulse generating device. We exposed mammalian cells, transfected with a…

QH301-705.5Microsecond pulsed electric fieldSecreted alkaline phosphataseReporter assaymicrosecond pulsed electric field; inducible gene transcription control; reporter assay; secreted alkaline phosphatase; mammalian cells; cell line; NF-κBTransfectionCatalysisArticleNF-κBInorganic Chemistry03 medical and health sciencesMice0302 clinical medicineElectricityinducible gene transcription controlAnimalsHumansmammalian cellsBiology (General)Physical and Theoretical ChemistryInducible gene transcription controlQD1-999Molecular BiologySpectroscopy030304 developmental biology0303 health sciencessecreted alkaline phosphataseOrganic ChemistryNF‐κBreporter assayNF-kappa BMammalian cells:NATURAL SCIENCES::Physics [Research Subject Categories]General Medicinecell linemicrosecond pulsed electric field3. Good healthComputer Science ApplicationsChemistryGene Expression Regulation030220 oncology & carcinogenesismicrosecond pulsed electric field ; inducible gene transcription control ; reporter assay ; secreted alkaline phosphatase ; mammalian cells ; cell line ; NF-κBCell lineInternational Journal of Molecular Sciences
researchProduct

Pdl1 Is a Putative Lipase that Enhances Photorhabdus Toxin Complex Secretion

2012

The Toxin Complex (TC) is a large multi-subunit toxin first characterized in the insect pathogens Photorhabdus and Xenorhabdus, but now seen in a range of pathogens, including those of humans. These complexes comprise three protein subunits, A, B and C which in the Xenorhabdus toxin are found in a 4∶1∶1 stoichiometry. Some TCs have been demonstrated to exhibit oral toxicity to insects and have the potential to be developed as a pest control technology. The lack of recognisable signal sequences in the three large component proteins hinders an understanding of their mode of secretion. Nevertheless, we have shown the Photorhabdus luminescens (Pl) Tcd complex has been shown to associate with th…

QH301-705.5Protein subunitImmunologyBacterial ToxinsMicrobiologiaXenorhabdusPathogenesisBiologymedicine.disease_causeMicrobiologyVirulence factorXenorhabdusMicrobiology03 medical and health sciencesBacterial ProteinsVirologyPhotorhabdus luminescensManducaGeneticsmedicineEscherichia coliGram NegativeAnimalsSecretionBiology (General)Molecular BiologyEscherichia coliBiologyMicrobial PathogensBacterial Secretion Systems030304 developmental biology0303 health sciences030306 microbiologyToxinMembrane ProteinsLipaseRC581-607biology.organism_classificationBacterial PathogensHost-Pathogen InteractionLarvaBacteris patògensParasitologyImmunologic diseases. AllergyPhotorhabdusProteïnesPhotorhabdusResearch ArticlePLoS Pathogens
researchProduct

Development of extracellular vesicle-based medicinal products: A position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspecti…

2021

International audience; Extracellular vesicles (EV) are emergent therapeutic effectors that have reached clinical trial investigation. To translate EV-based therapeutic to clinic, the challenge is to demonstrate quality, safety, and efficacy, as required for any medicinal product. EV research translation into medicinal products is an exciting and challenging perspective. Recent papers, provide important guidance on regulatory aspects of pharmaceutical development, defining EVs for therapeutic applications and critical considerations for the development of potency tests. In addition, the ISEV Task Force on Regulatory Affairs and Clinical Use of EV-based Therapeutics as well as the Exosomes C…

Quality ControlKnowledge management[SDV.BIO]Life Sciences [q-bio]/BiotechnologyBiological medicinal productsmedia_common.quotation_subjectDrug Compounding[SDV]Life Sciences [q-bio]Regulatory requirementsPharmaceutical ScienceMarketing authorizationExosomesChemistry Techniques Analytical03 medical and health sciencesExtracellular Vesicles0302 clinical medicineDrug DevelopmentDrug Stability[CHIM]Chemical SciencesHumansQuality (business)ComputingMilieux_MISCELLANEOUS030304 developmental biologymedia_commonCell-free therapySecretome0303 health sciencesClinical Trials as TopicClinical-grade EVScientific progressbusiness.industryDrug Administration RoutesExtracellular vesicleDrugs InvestigationalRegulatory affairs3. Good health[SDV.BIO] Life Sciences [q-bio]/BiotechnologyClinical trialEuropeAnalytics030220 oncology & carcinogenesisPosition paperMedicinal productsBusinessMicrovesicles
researchProduct

The ER-Membrane Transport System Is Critical for Intercellular Trafficking of the NSm Movement Protein and Tomato Spotted Wilt Tospovirus.

2015

Plant viruses move through plasmodesmata to infect new cells. The plant endoplasmic reticulum (ER) is interconnected among cells via the ER desmotubule in the plasmodesma across the cell wall, forming a continuous ER network throughout the entire plant. This ER continuity is unique to plants and has been postulated to serve as a platform for the intercellular trafficking of macromolecules. In the present study, the contribution of the plant ER membrane transport system to the intercellular trafficking of the NSm movement protein and Tomato spotted wilt tospovirus (TSWV) is investigated. We showed that TSWV NSm is physically associated with the ER membrane in Nicotiana benthamiana plants. An…

RNA viruses0301 basic medicineLeavesCell MembranesNicotiana benthamianaPlant ScienceEndoplasmic ReticulumPathology and Laboratory MedicineBiochemistrySolanum lycopersicumTospovirusBunyavirusesMedicine and Health SciencesArabidopsis thalianaMovement proteinBiology (General)Integral membrane proteinSecretory PathwaybiologyPlant BiochemistryPlant AnatomyPlasmodesmataProteïnes de membranafood and beveragesPlantsPlants Genetically ModifiedCell biologyTransport proteinPlant Viral Movement ProteinsProtein TransportMedical MicrobiologyCell ProcessesViral PathogensVirusesPathogensCellular Structures and OrganellesTomato Spotted Wilt VirusResearch ArticleBioquímicaCell PhysiologyQH301-705.5Arabidopsis ThalianaImmunologyPlant PathogensBrassicaPlasmodesmaResearch and Analysis MethodsMicrobiologyPlant Viral Pathogens03 medical and health sciencesModel OrganismsPlant and Algal ModelsVirologyTobaccoGeneticsIntegral Membrane ProteinsSecretionMicrobial PathogensMolecular BiologyPlant DiseasesBiology and life sciencesEndoplasmic reticulumfungiOrganismsMembrane ProteinsCell BiologyPlant PathologyRC581-607biology.organism_classificationVirosis (Plantes)VirologyPlant Leaves030104 developmental biologyMembrane TraffickingParasitologyImmunologic diseases. AllergyPLoS Pathogens
researchProduct

Microbial analysis of raw cows' milk used for cheese-making: influence of storage treatments on microbial composition and other technological traits

2010

Raw milk used to produce Grana cheese was subjected to several treatment regimes, including varying temperatures and storage times. Milk from morning and evening milking were transferred to a dairy factory sepa- rately (double delivery) or together (single delivery), after storage at the farm for 12 h; in the former case, milk was stored at 12 or 8°C, whereas, in the latter, it was kept at ambient temperature or 18°C. Values of pH of the vat milk were lower for milk samples kept at room temperature, while other physico-chemical parameters and rheological characteristics tested did not show significant differ- ences linked to the different storage temperatures of milk used for ‘‘Grana Trenti…

Raw cows’ milkPhysiologyMicroorganismfood and beveragesDGGE; Grana cheese; refrigeration; milk microfloraDenaturing gradient gel electrophoresisGeneral MedicineRaw milkBiologyGrana cheesemedicine.disease_causeApplied Microbiology and BiotechnologyMilkingfluids and secretionsPsychrotrophic bacteriaMost probable numberRefrigerationmedicineCheesemakingFood scienceDGGETemperature gradient gel electrophoresisBiotechnologyMesophileMilk microflora
researchProduct

Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease…

2009

Alcadeins (Alcs) constitute a family of neuronal type I membrane proteins, designated Alc(alpha), Alc(beta), and Alc(gamma). The Alcs express in neurons dominantly and largely colocalize with the Alzheimer amyloid precursor protein (APP) in the brain. Alcs and APP show an identical function as a cargo receptor of kinesin-1. Moreover, proteolytic processing of Alc proteins appears highly similar to that of APP. We found that APP alpha-secretases ADAM 10 and ADAM 17 primarily cleave Alc proteins and trigger the subsequent secondary intramembranous cleavage of Alc C-terminal fragments by a presenilin-dependent gamma-secretase complex, thereby generating "APP p3-like" and non-aggregative Alc pe…

Receptors Cell SurfaceADAM17 ProteinBiochemistryPresenilinCell LineADAM10 ProteinAmyloid beta-Protein PrecursorMiceAlzheimer Diseasemental disordersAmyloid precursor proteinmedicineAnimalsHumansReceptorMolecular BiologyPeptide sequencechemistry.chemical_classificationbiologyProtein Synthesis Post-Translational Modification and DegradationCalcium-Binding ProteinsMembrane ProteinsCell Biologymedicine.diseaseMolecular biologyAmino acidProtease NexinsADAM ProteinsMembrane proteinchemistrybiology.proteinAlzheimer's diseaseAmyloid Precursor Protein SecretasesPeptidesAmyloid precursor protein secretaseThe Journal of biological chemistry
researchProduct